Back to stories
Industry

UK Government Courts Anthropic With London Expansion and Dual Listing Proposals

Michael Ouroumis2 min read
UK Government Courts Anthropic With London Expansion and Dual Listing Proposals

The British government is actively courting Anthropic with a package of proposals that includes a London office expansion and a potential dual stock listing, according to a Financial Times report published Saturday citing multiple people with knowledge of the plans.

What the UK Is Offering

Staff at the Department for Science, Innovation and Technology (DSIT) have sketched out a range of options for the Claude AI maker, from expanding its existing London footprint to the more ambitious prospect of listing shares on both U.S. and UK exchanges. The proposals are set to be presented to Anthropic CEO Dario Amodei during a planned visit to the UK in late May, when he is expected to meet European customers and policymakers.

Prime Minister Keir Starmer's office at No. 10 is reportedly supportive of DSIT's efforts. Business Secretary Peter Kyle said Anthropic was among the fast-growing companies he wanted investing more in Britain. London Mayor Sadiq Khan has also invited the company to relocate to the capital, citing a "stable, proportionate and pro-innovation environment."

The Pentagon Fallout

The UK's overture comes amid Anthropic's escalating dispute with the U.S. government. The Pentagon designated Anthropic a national-security supply-chain risk after the company refused to allow the military to use its Claude chatbot for surveillance or autonomous weapons applications. The resulting contract termination and blacklisting — temporarily blocked by a federal judge — has created what British officials view as a strategic opening.

One government official described a UK dual listing to the Financial Times as "the dream," though the same person acknowledged it remained a "highly unlikely" outcome.

Anthropic's UK Footprint

Anthropic already has approximately 200 employees in Britain, including researchers, and appointed former Prime Minister Rishi Sunak as a senior adviser last year. The company is valued at roughly $380 billion and counts Amazon and Alphabet among its backers.

The AI firm is also reportedly in preliminary discussions with Goldman Sachs, JPMorgan Chase, and Morgan Stanley about a potential IPO, with an October listing being considered.

Wider Implications

Britain's bid for Anthropic reflects a broader strategy to position London as a global hub for AI companies, particularly those facing regulatory or political headwinds in the United States. If successful, even a partial relocation or expanded UK presence would represent a significant win for the Starmer government's tech agenda and could influence how other AI firms weigh their international expansion plans.

The outcome may also shape the ongoing debate about how Western democracies balance national security interests with the commercial freedom of AI companies — a tension that has defined Anthropic's relationship with Washington throughout 2026.

Learn AI for Free — FreeAcademy.ai

Take "AI for Business: Practical Implementation" — a free course with certificate to master the skills behind this story.

More in Industry

Google Ships Antigravity 2.0: A Standalone Agent Platform That Retires the Gemini CLI
Industry

Google Ships Antigravity 2.0: A Standalone Agent Platform That Retires the Gemini CLI

At I/O 2026, Google relaunched Antigravity as a standalone agent-orchestration platform with a CLI that replaces the Gemini CLI, an SDK, Managed Agents in the Gemini API, and an enterprise tier — all defaulting to Gemini 3.5 Flash.

10 min ago2 min read
Alibaba's Zhenwu M890 Claims 3x Nvidia's H20, Ships With Qwen 3.7-Max
Industry

Alibaba's Zhenwu M890 Claims 3x Nvidia's H20, Ships With Qwen 3.7-Max

Alibaba's chip unit T-Head unveiled the Zhenwu M890 AI accelerator, claiming 3x the agentic-inference performance of Nvidia's H20 and 144GB of HBM3, paired with the Qwen 3.7-Max model — a full domestic stack as US export controls tighten.

1 hours ago2 min read
Cohere Buys Reliant AI to Build 'North for Pharma' Sovereign Biopharma Agents
Industry

Cohere Buys Reliant AI to Build 'North for Pharma' Sovereign Biopharma Agents

Cohere has acquired Montréal- and Berlin-based biopharma startup Reliant AI, folding its automated research workbench into the North platform to launch 'North for Pharma' — its second acquisition in a month as it doubles down on sovereign, regulated-industry AI.

3 hours ago2 min read